Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

PRIAS: Active surveillance for men with low risk prostate cancer

EMUC 2019

14 - 17 Nov 2019

Published: 24 Feb 2020

Views: 831

Rating:

Save

Prof Monique J. Roobol - Erasmus University Medical Center, Rotterdam, The Netherlands

Prof Monique Roobol speaks to ecancer at EMUC 2019 in Vienna about active surveillance for men with low risk prostate cancer.

She discusses the PRIAS study, which studies active surveillance of men with low risk prostate cancer in order to understand better when to switch to active treatment.

Hopefully this will reduce the occurrence of over-diagnosis.

Related Videos

Genomic testing: Awareness and effective communication between healthcare...

Prof Richard Simcock and Antonella Cardone

Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of...

Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina

The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )

iCCaRE Consortium for Black Men: Second Discussion

Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina

iCCaRE Consortium for Black Men: Second Discussion ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Why tumour markers are not recommended as screening tests

Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines

Why tumour markers are not recommended as screening tests ( Dr Frederic Ting - Riverside Medical Center, Bacolod, Philippines )

Lung cancer screening and treatment in the Philippines

Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines

Lung cancer screening and treatment in the Philippines ( Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines )

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk...

Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA

Gemtuzumab ozogamicin plus chemotherapy improves outcomes in intermediate-risk cytogenetic AML ( Dr Eunice Wang - Roswell Park Comprehensive Cancer Center, New York, USA )

More from ecancer